Found 4 matching trials
Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of Statin PHASE3 Primary Objective:
To demonstrate the reduction of low-density lipoprotein...
Show More Location
Investigational Site Number 392028
Learn More & Join Trial
Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia PHASE2 The primary objective of the study is to evaluate the reduction of LDL-C by...
Show More Location
Cedars-Sinai Medical Center
Learn More & Join Trial
Phase III Study To Evaluate Alirocumab in Patients With Hypercholesterolemia Not Treated With a Statin (ODYSSEY CHOICE II) PHASE3 Primary Objective:
To demonstrate the reduction of low-density lipoprotein...
Show More Location
Investigational Site Number 840703
Learn More & Join Trial
Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography NA The primary objective was to evaluate the effect of PCSK9 inhibitors in add...
Show More Location
Zhejiang Provincial Hospital of Traditional Chinese Medicine
Learn More & Join Trial